BHVN Biohaven Ltd. Loading...

Loading chart...
Top Calls

No data yet

Price change since each call, adjusted for long/short direction. Results calculated:

Feed
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
Time Author Thesis Company / ticker Signal Since call Position Source
19:42
Sep 17
seedy19tron
BHVN long, SK deal should close
Author adds to a BHVN long in the $12s, arguing the SK hold lacks a walk-right under the 8-K and that prior regulator submissions make a pause foreseeable, so the deal should close. SCA risk flagged as a negative overlay.
BHVN Biohaven Ltd. Long — —
13:44
Sep 10
seedy19tron
Added BHVN at $13 position
Added to BHVN at $13 with freed capital from the MRNA short cover, increasing bullish exposure.
BHVN Biohaven Ltd. Long — —
11:16
Sep 10
seedy19tron
Long BHVN, SK deal should close Research
Buy BHVN around $12s as the SK deal should still close: no MAE termination clause, and the rodent metabolite finding was already disclosed to regulators and SK, so the hold is not a valid MAE.
BHVN Biohaven Ltd. Long — —
Log in to see ideas

About BHVN Investor Commentary

Across the available history and selected sources, Buzzberg tracks BHVN (Biohaven Ltd.) across 4 sources: 6 bullish vs 0 bearish calls from 4 authors. Historical directional balance: 46% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 13 total trade ideas tracked. Latest voices: seedy19tron.